| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marie Fabritius, Haithem Chtioui, Giovanni Battistella, Jean-Marie Annoni, Kim Dao, Bernard Favrat, Eleonora Fornari, Estelle Lauer, Philippe Maeder, Christian Girou. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. Analytical and bioanalytical chemistry. vol 405. issue 30. 2014-06-27. PMID:24202191. |
comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. |
2014-06-27 |
2023-08-12 |
human |
| Nicola Mastroianni, Cristina Postigo, Miren Lopez de Alda, Damia Barcel. Illicit and abused drugs in sewage sludge: method optimization and occurrence. Journal of chromatography. A. vol 1322. 2014-06-26. PMID:24275487. |
to the authors' knowledge, nine out of the 20 selected analytes, namely, cocaethylene, ephedrine, heroin, alprazolam, lysergic acid diethylamide (lsd), its metabolite 2-oxo-3-hydroxy-lsd, and the cannabinoids Δ(9)-tetrahydrocannabinol (thc), cannabinol (cbn) and cannabidiol (cbd), are investigated for the first time in this matrix. |
2014-06-26 |
2023-08-12 |
Not clear |
| Benjamin Chadwick, Michael L Miller, Yasmin L Hur. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. Frontiers in psychiatry. vol 4. 2014-06-24. PMID:24133461. |
cannabis contains psychoactive components, notably Δ(9)-tetrahydrocannabinol (thc), that interfere with the brain's endogenous endocannabinoid system, which is critically involved in both pre- and post-natal neurodevelopment. |
2014-06-24 |
2023-08-12 |
human |
| Raymond J M Niesink, Margriet W van Laa. Does Cannabidiol Protect Against Adverse Psychological Effects of THC? Frontiers in psychiatry. vol 4. 2014-06-24. PMID:24137134. |
recent studies have suggested a possible protective effect of another cannabinoid, cannabidiol (cbd). |
2014-06-24 |
2023-08-12 |
Not clear |
| Donald E Greydanus, Elizabeth K Hawver, Megan M Greydanus, Joav Merric. Marijuana: current concepts(†). Frontiers in public health. vol 1. 2014-06-24. PMID:24350211. |
this paper considers current research on use of cannabis sativa and its constituents such as the cannabinoids. |
2014-06-24 |
2023-08-12 |
Not clear |
| Donald E Greydanus, Elizabeth K Hawver, Megan M Greydanus, Joav Merric. Marijuana: current concepts(†). Frontiers in public health. vol 1. 2014-06-24. PMID:24350211. |
topics reviewed include prevalence of cannabis (pot) use, other drugs consumed with pot, the endocannabinoid system, use of medicinal marijuana, medical adverse effects of cannabis, and psychiatric adverse effects of cannabis use. |
2014-06-24 |
2023-08-12 |
Not clear |
| Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souz. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in psychiatry. vol 5. 2014-06-24. PMID:24904437. |
acute exposure to both cannabis and synthetic cannabinoids (spice/k2) can produce a full range of transient psychotomimetic symptoms, cognitive deficits, and psychophysiological abnormalities that bear a striking resemblance to symptoms of schizophrenia. |
2014-06-24 |
2023-08-13 |
Not clear |
| Ismael Galve-Roperh, Valerio Chiurchiù, Javier Díaz-Alonso, Monica Bari, Manuel Guzmán, Mauro Maccarron. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Progress in lipid research. vol 52. issue 4. 2014-06-20. PMID:24076098. |
cannabinoids, the active components of cannabis (cannabis sativa) extracts, have attracted the attention of human civilizations for centuries, much earlier than the discovery and characterization of their substrate of action, the endocannabinoid system (ecs). |
2014-06-20 |
2023-08-12 |
human |
| Sebastien Anizan, Garry Milman, Nathalie Desrosiers, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and bioanalytical chemistry. vol 405. issue 26. 2014-06-12. PMID:23954944. |
oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. |
2014-06-12 |
2023-08-12 |
Not clear |
| Sebastien Anizan, Garry Milman, Nathalie Desrosiers, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and bioanalytical chemistry. vol 405. issue 26. 2014-06-12. PMID:23954944. |
oral fluid (of) is an alternative biological matrix for monitoring cannabis intake in drug testing, and drugged driving (duid) programs, but of cannabinoid test interpretation is challenging. |
2014-06-12 |
2023-08-12 |
Not clear |
| Sebastien Anizan, Garry Milman, Nathalie Desrosiers, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and bioanalytical chemistry. vol 405. issue 26. 2014-06-12. PMID:23954944. |
we compared differences in of cannabinoid concentrations from 19 h before to 30 h after smoking a 6.8% thc cigarette in chronic frequent and occasional cannabis smokers. |
2014-06-12 |
2023-08-12 |
Not clear |
| N Rimmerman, D Ben-Hail, Z Porat, A Juknat, E Kozela, M P Daniels, P S Connelly, E Leishman, H B Bradshaw, V Shoshan-Barmatz, Z Voge. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell death & disease. vol 4. 2014-06-12. PMID:24309936. |
cannabidiol (cbd) is a non-psychoactive plant cannabinoid that inhibits cell proliferation and induces cell death of cancer cells and activated immune cells. |
2014-06-12 |
2023-08-12 |
Not clear |
| Nathalie A Desrosiers, Sarah K Himes, Karl B Scheidweiler, Marta Concheiro-Guisan, David A Gorelick, Marilyn A Huesti. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical chemistry. vol 60. issue 4. 2014-06-05. PMID:24563491. |
phase i and ii cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. |
2014-06-05 |
2023-08-12 |
Not clear |
| Sylvina M Raver, Sarah P Haughwout, Asaf Kelle. Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 38. issue 12. 2014-06-03. PMID:23822952. |
the endocannabinoid system upon which marijuana acts is one such system. |
2014-06-03 |
2023-08-12 |
mouse |
| Christopher Y Hopkins, Brandi L Gilchris. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. The Journal of emergency medicine. vol 45. issue 4. 2014-05-29. PMID:23890687. |
cannabinoid hyperemesis syndrome (chs) was initially described in 2004 and remains an under-recognized clinical entity that occurs in chronic heavy marijuana smokers. |
2014-05-29 |
2023-08-12 |
Not clear |
| Giuseppe Tortoriello, Claudia V Morris, Alan Alpar, Janos Fuzik, Sally L Shirran, Daniela Calvigioni, Erik Keimpema, Catherine H Botting, Kirstin Reinecke, Thomas Herdegen, Michael Courtney, Yasmin L Hurd, Tibor Harkan. Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. The EMBO journal. vol 33. issue 7. 2014-05-28. PMID:24469251. |
psychoactive constituents from cannabis spp., particularly Δ(9)-tetrahydrocannabinol (thc), bind to cannabinoid receptors in the fetal brain. |
2014-05-28 |
2023-08-12 |
human |
| Cristóbal S Berry-Cabán, Juliana Ee, Victoria Ingram, Carlos E Berry, Eugene H Ki. Synthetic cannabinoid overdose in a 20-year-old male US soldier. Substance abuse. vol 34. issue 1. 2014-05-26. PMID:23327506. |
although synthetic cannabinoids, collectively referred to as "spice," are similar in structure to the active metabolites found in cannabis, significant concerns exist regarding the severity of short- and long-term medical and psychiatric sequelae. |
2014-05-26 |
2023-08-12 |
Not clear |
| Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani, Giancarlo Discepoli, Sonia Liberati, Attilio Olivieri, Matteo Santoni, Giorgio Santoni, Pietro Leoni, Massimo Nabiss. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. International journal of cancer. vol 134. issue 11. 2014-05-22. PMID:24293211. |
cannabidiol (cbd) is a non-psychoactive cannabinoid with antitumoural activities, and the transient receptor potential vanilloid type-2 (trpv2) channel has been reported as a potential cbd receptor. |
2014-05-22 |
2023-08-12 |
human |
| Charlotte Rapp, Anna Walter, Erich Studerus, Hilal Bugra, Corinne Tamagni, Michel Röthlisberger, Stefan Borgwardt, Jacqueline Aston, Anita Riecher-Rössle. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis. Psychiatry research. vol 214. issue 2. 2014-05-16. PMID:24054726. |
overall, we found negative associations of current cannabis use with grey matter volume of the cingulate cortex, a region rich in cannabinoid cb1 receptors. |
2014-05-16 |
2023-08-12 |
human |
| Ben Warner, Stuart Cairns, Andy Ston. A rare case of cannabis hyperemesis syndrome relieved by hot water bathing. Clinical medicine (London, England). vol 14. issue 1. 2014-05-15. PMID:24532755. |
we present here a case of cannabinoid hyperemesis syndrome (chs), which is an under-recognised disorder presenting in chronic abusers of cannabis typically as cyclical vomiting relieved by frequent hot baths. |
2014-05-15 |
2023-08-12 |
Not clear |